Do Traders Think Bone Biologics Corp (BBLG) Can Keep Climbing Thursday?

Overall market sentiment has been high on Bone Biologics Corp (BBLG) stock lately. BBLG receives a Bullish rating from InvestorsObserver Stock Sentiment Indicator.

Bone Biologics Corp has a Bullish sentiment reading. Find out what this means for you and get the rest of the rankings on BBLG!

See Full BBLG Report

What is Stock Sentiment?

Sentiment is a very short-term indicator that is entirely technical. There is no information about the health of profitability of the underlying company in our sentiment score. As a technical indicator, news about the stock, or company, such as an earnings release or other event, could move the stock counter to the recent trend. Recent trends are a good indicator of current market sentiments. In its most basic form, stocks that are trending up are desirable by investors while stocks currently falling must be unattractive. InvestorsObserver's Sentimental Indicator tracks both changes in price and volume to analyze the most recent trends. Typically an increase in volume indicates ongoing trends are getting stronger, while a decrease in volume usually signals an end to the current trend. Available options can also represent current sentiments for a given stock. Since investors are able to bet on future trends of stocks using options, we consider the ratio of calls to puts when analyzing market sentiments .

What's Happening With BBLG Stock Today?

Bone Biologics Corp (BBLG) stock has risen 0.89% while the S&P 500 has fallen -0.6% as of 10:22 AM on Thursday, Aug 3. BBLG is up $0.01 from the previous closing price of $1.33 on volume of 53,613 shares. Over the past year the S&P 500 has gained 9.66% while BBLG has fallen -96.52%. BBLG lost -$9.97 per share in the over the last 12 months.

More About Bone Biologics Corp

Bone Biologics Corp is a healthcare solutions provider based in the United States. As a biotechnology firm, it engages its efforts in developing therapeutics to aid bone regeneration. The company's portfolio comprises its lead product, NELL-1, which is a bone void filler. Bone Biologics' technology has application in the surgical specialties of spinal, orthopedic, general orthopedic, plastic reconstruction, neurosurgery, interventional radiology, and sports medicine. Click Here to get the full Stock Report for Bone Biologics Corp stock.